Avantor Inc. (AVTR)
NYSE: AVTRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AVTR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $10.38B
- Forward P/E
- 17.48
- EPS (TTM)
- -$0.84
- Dividend yield
- None
- 52-week range
- 7.27 – 16.38
- Day range
- 15.04 – 15.52
- Volume / Avg
- 6.01M / 9.45M
- Beta
- —
- Shares outstanding
- 676.36M
- Next earnings
- Oct 28, 2026
52-week range
AVTR stock today
On Oct 7, AVTR ended the session at $15.35, shedding $0.08 (0.52%), versus the S&P 500's 0.22% decline. Shares are 6.3% below their 52-week high of $16.38, set on Oct 6, 2026 and 111.3% above the 52-week low of $7.27, near the top of the past year's range. AVTR is up 33.9% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 14.0%.
Avantor has posted a net loss over the last twelve months (EPS of -$0.84), so its P/E ratio is not meaningful. The company is scheduled to report Sep/2026 results on Oct 28 before the market opens; analysts expect EPS of $0.21.
Summary generated from market data by MetaCap's automated system. Methodology
About Avantor
Company profileAvantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- CEO
- Mr. Emmanuel Ligner
- Headquarters
- Radnor, PA
- Employees
- 13,500
- IPO year
- 2019
- Website
- avantorsciences.com
Financial highlights
Full financialsIn fiscal 2025, Avantor generated $6.55 billion in revenue, down 3.4% from fiscal 2024, its first annual decline since 2024. Avantor reported a net loss of $530.2 million, compared with net income of $711.5 million a year earlier. Gross margin was 32.7% (down from 33.6%) and operating margin -3.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|
| Revenue | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B |
| Growth | -3.41% | -2.64% | -7.26% | +1.71% | +15.52% |
| Net income | $-530.20M | $711.50M | $321.10M | $686.50M | $572.60M |
| EPS (diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
Analyst forecast
ForecastConsensus (16 analysts)
hold
Avg. price target
$14.78-3.71%
- Strong buy 0
- Buy 2
- Hold 13
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 28, 2026
- EPS estimate
- $0.21
- Last reported (Q1 2026)
- Apr 29, 2026
- EPS actual vs est.
- $0.06 vs —
AVTR news
All AVTR newsAvantor peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TXG10x Genomics Inc. Class A | 76.10 | -5.65% | $9.92B | vs AVTR |
| BIOBio-Rad Laboratories Inc. Class A | 367.92 | -0.25% | $9.84B | vs AVTR |
| BRKRBruker Corporation | 59.72 | -1.29% | $9.10B | vs AVTR |
| ALMRAlamar Biosciences Inc. | 27.77 | -13.92% | $1.93B | vs AVTR |
| CIRCCircle8 Group Inc. | 0.46 | -7.26% | $52.63M | vs AVTR |
| RPIDRapid Micro Biosystems Inc. Class A | 0.8977 | -4.76% | $45.03M | vs AVTR |
| PRPOPrecipio Inc. | 23.52 | +0.30% | $42.11M | vs AVTR |
| HBIOHarvard Bioscience Inc. | 8.50 | -0.70% | $38.69M | vs AVTR |
Indexes, lists and sector
Avantor stock FAQ
What is Avantor's stock price today?
AVTR last traded at $15.35 as of Oct 7, 4:00 PM EDT, down 0.52% on the day. Prices are delayed at least 15 minutes.
When is Avantor's next earnings date?
Avantor is expected to report earnings on Wednesday, October 28, 2026. Analysts expect EPS of $0.21.
Who is Avantor's CEO?
Mr. Emmanuel Ligner is the chief executive officer of Avantor Inc., which has about 13,500 employees.
What is the AVTR 52-week high?
The 52-week high for AVTR is $16.38 and the 52-week low is $7.27. The stock is currently 6.3% below its high.